UBS Group’s Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CNDA.WS Stock Holding History

UBS Group’s Portfolio CNDA.WS Stock Details CNDA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-132	Closed	-$9	–	10156
2023 Q3	$9	Sell	132 -733	-85%	-$49	﹤0.01%	9234
2023 Q2	$35	Buy	+865	New	+$49	﹤0.01%	8642

Other funds holding CNDA.WS

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

UBS Group's CNDA.WS Position: Q4 2023 in Review

UBS Group sold out of Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 (CNDA.WS) in Q4 2023, closing a stake of 132 shares — an estimated $9 sold.

UBS Group first reported a position in CNDA.WS in Q2 2023 and held it in 2 quarters. The position peaked at $35 in Q2 2023. 27 funds tracked by Wall St. Rank hold CNDA.WS as of Q4 2023.

UBS Group reported no remaining Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position as of Q4 2023 after selling out during the quarter.
UBS Group sold 132 Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 shares in Q4 2023, an estimated $9.
UBS Group first reported a position in Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 in Q2 2023 and held it in 2 quarters.
UBS Group's Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 position peaked at $35 in Q2 2023.
27 funds tracked by Wall St. Rank held Concord Acquisition Corp II Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.